Okada, M.; Suzuki, S.; Togashi, K.; Sugai, A.; Yamamoto, M.; Kitanaka, C.
Targeting Folate Metabolism Is Selectively Cytotoxic to Glioma Stem Cells and Effectively Cooperates with Differentiation Therapy to Eliminate Tumor-Initiating Cells in Glioma Xenografts. Int. J. Mol. Sci. 2021, 22, 11633.
https://doi.org/10.3390/ijms222111633
AMA Style
Okada M, Suzuki S, Togashi K, Sugai A, Yamamoto M, Kitanaka C.
Targeting Folate Metabolism Is Selectively Cytotoxic to Glioma Stem Cells and Effectively Cooperates with Differentiation Therapy to Eliminate Tumor-Initiating Cells in Glioma Xenografts. International Journal of Molecular Sciences. 2021; 22(21):11633.
https://doi.org/10.3390/ijms222111633
Chicago/Turabian Style
Okada, Masashi, Shuhei Suzuki, Keita Togashi, Asuka Sugai, Masahiro Yamamoto, and Chifumi Kitanaka.
2021. "Targeting Folate Metabolism Is Selectively Cytotoxic to Glioma Stem Cells and Effectively Cooperates with Differentiation Therapy to Eliminate Tumor-Initiating Cells in Glioma Xenografts" International Journal of Molecular Sciences 22, no. 21: 11633.
https://doi.org/10.3390/ijms222111633
APA Style
Okada, M., Suzuki, S., Togashi, K., Sugai, A., Yamamoto, M., & Kitanaka, C.
(2021). Targeting Folate Metabolism Is Selectively Cytotoxic to Glioma Stem Cells and Effectively Cooperates with Differentiation Therapy to Eliminate Tumor-Initiating Cells in Glioma Xenografts. International Journal of Molecular Sciences, 22(21), 11633.
https://doi.org/10.3390/ijms222111633